2nd Quarter - Report

KOUNTOUPES DENHAM CARR & REID, LLC for BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 15, 2019 $50,000 Replaced
2nd Quarter - Amendment Mar 29, 2021 $50,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Issues related to blood cancer research funding included in the FY 2020 Labor-HHS and Department of Defense Appropriations Bills.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LORI DENHAM —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Medicare/Medicaid MMM

Issues related to Medicare Part D as related to blood cancer beneficiaries.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LORI DENHAM —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to blood cancer research, diagnosis, treatment and cures including coverage and reimbursement of cancer treatment therapies and issues related to H. R. 1730/S.741, the Cancer Drug Parity Act of 2019. Issues related to patient protections for blood cancer patients. Issues related to insurance market stabilization. Issues related to pediatric cancer.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LORI DENHAM —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1730 (116th), S. 741 (116th)

Pharmacy PHA

Issues related to the cost of care and protecting patient access to blood cancer treatment. Issues related to specialty drug tiers.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LORI DENHAM —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.